| Patents for C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102) |
|---|
| 04/27/2005 | CN1609617A Composition and method for diagnosing and preventing serious acute respiratory syndrome(SARS) |
| 04/21/2005 | WO2005034844A2 Exosite-directed thrombin inhibitors |
| 03/29/2005 | US6872520 Peptide for use in the detection of viral infection and diseases |
| 03/23/2005 | CN1597953A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/17/2005 | WO2005023284A1 Ion channel modulators |
| 03/17/2005 | CA2579635A1 Peptides that inhibit complement activation |
| 03/17/2005 | CA2537798A1 Cytidine deaminase activators, deoxycytidine deaminase activators, vif antagonists, and methods of screening for molecules thereof |
| 03/10/2005 | CA2543078A1 Diagnosis and treatment of micobacterial infections |
| 03/03/2005 | WO2005018575A2 Estrogen receptor modulators and uses thereof |
| 03/03/2005 | CA2536946A1 Estrogen receptor modulators and uses thereof |
| 02/24/2005 | WO2005016957A1 REAGENT FOR AMPLIFYING AMYLOID FIBROSIS OF AMYLOID β-PROTEIN |
| 02/24/2005 | US20050042602 Monitoring immunologic, Hematologic and inflammatory diseases |
| 02/17/2005 | WO2003082019A9 Peptides with anti-hypertensive properties |
| 02/15/2005 | US6855801 Peptides modulating activities of heparin other glycosaminoglycans or proteoglycans |
| 02/10/2005 | WO2005011607A2 Treatment of cancers expressing p95 erbb2 |
| 02/03/2005 | WO2005009363A2 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies |
| 02/03/2005 | WO2005009217A2 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 01/27/2005 | WO2005007680A1 Arginine/lysine-enriched peptides |
| 01/19/2005 | EP1498427A1 Immunoglobulins devoid of light chains |
| 01/19/2005 | CN1566153A Method for separating and extracting saccule peptides from saccules rotundus of rabbits |
| 01/12/2005 | EP1494701A2 Immunosuppressant compounds, methods and uses related thereto |
| 01/06/2005 | US20050003345 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 01/06/2005 | CA2529943A1 Peptides derived from the protein mmp-2, and the use thereof in antitumoral immunotherapy |
| 01/05/2005 | EP1492882A1 Methods and reagents for assaying protein kinase activity |
| 01/05/2005 | EP1492409A2 Peptides with anti-hypertensive properties |
| 12/30/2004 | US20040266991 Biologically active peptides and their use for repairing injured nerves |
| 12/29/2004 | WO2004112572A2 Monitoring immunologic, hematologic and inflammatory diseases |
| 12/29/2004 | WO2004078926A3 Immunologigal markers |
| 12/29/2004 | CA2529045A1 Monitoring immunologic, hematologic and inflammatory diseases |
| 12/23/2004 | WO2004110390A2 Anti-cd74 immunoconjugates and methods |
| 12/23/2004 | US20040258619 Diaminedioxime radiometal complexes |
| 12/23/2004 | CA2529496A1 Anti-cd74 immunoconjugates and methods |
| 12/02/2004 | US20040241791 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 12/02/2004 | US20040241664 Protein Hydrolysates Enriched In Peptides Having A Carboxy Terminal Proline Residue |
| 11/25/2004 | WO2004093662A3 Method for detecting prognosis of cancer |
| 11/24/2004 | EP1479692A1 Peptides responsive to antibodies against a consensus peptide of the CS4-CFA/I family proteins |
| 11/17/2004 | EP1055125B1 Interaction between cyclin d1 and steroid receptor co-activators |
| 11/04/2004 | WO2004093662A2 Method for detecting prognosis of cancer |
| 11/04/2004 | US20040219203 Anti-CD74 immunoconjugates and methods |
| 11/03/2004 | EP1471936A2 Hiv vaccine and method of use |
| 11/02/2004 | US6811970 Measurement of dimerization of viral polymerase; obtain sample containing viral dimerized proteins, incubate with binding agent, determine the amount of complex formed |
| 10/26/2004 | CA2137237C Purified forms of dnase |
| 10/21/2004 | US20040208884 Administering construct in conjugated or unconjugated form and in combination with immunogenic carrier to induce antibodies; anticarcinogenic agents |
| 10/20/2004 | EP0959895B1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins |
| 10/14/2004 | US20040202761 Cocoa flavor precursor peptides |
| 10/11/2004 | CA2423897A1 Methods for treating lung infections and lung tumors and for treating and preventing lung metastases |
| 10/07/2004 | CA2520257A1 Long acting biologically active conjugates |
| 09/30/2004 | WO2004083154A1 Improved extraction process |
| 09/30/2004 | CA2518722A1 Improved extraction process |
| 09/29/2004 | EP1147130A4 Alpha-conotoxin peptides |
| 09/16/2004 | WO2004078926A2 Immunologigal markers |
| 09/16/2004 | WO2004047762A3 Methods for treating cancer using porimin as a target |
| 09/16/2004 | US20040180395 Method for detecting calpain3 activity in a biological sample and peptides for implementing said method |
| 09/15/2004 | EP1007095B1 CHIMERIC TOXINS COMPRISING GnRH FOR TARGETED THERAPY |
| 09/08/2004 | CN1527727A Improved chelator conjugates |
| 09/01/2004 | EP1451209A2 Tetra-,penta-,hexa- and heptapeptides having antiangiogenic activity |
| 08/11/2004 | CN1161372C Novel peptide having biological activity |
| 08/05/2004 | WO2004065547A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 08/05/2004 | CA2513308A1 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 07/22/2004 | US20040142860 Central nervous system-derived immune privilege factor and uses thereof |
| 07/21/2004 | EP1438329A1 Biologically active peptides and their use for repairing injured nerves |
| 07/21/2004 | CN1514878A Method for detecting calpain 3 activity in biological sample and peptides for implementsing said method |
| 07/15/2004 | WO2004042350A3 Using amines or amino acids as mobile phase modifiers in chromatography |
| 07/15/2004 | WO2003082197A3 Immunosuppressant compounds, methods and uses related thereto |
| 07/14/2004 | EP1436318A2 Ncam binding compounds |
| 07/07/2004 | CN1511044A Elogated and multiple spacers in activatible prodrugs |
| 06/30/2004 | EP0686161B1 Novel human beta2 integrin alpha subunit |
| 06/24/2004 | US20040121940 Anticancer prodrugs, enhance enzymatic activation rates |
| 06/22/2004 | CA2117904C Methods and reagents for diagnosis of autoantibodies |
| 06/10/2004 | WO2004047762A2 Methods for treating cancer using porimin as a target |
| 06/10/2004 | CA2507215A1 Methods for treating cancer using porimin as a target |
| 06/02/2004 | EP1423135A2 Methods for inhibiting angiogenesis |
| 05/27/2004 | WO2003031623A9 Cocoa flavour precursor peptides |
| 05/21/2004 | WO2004042350A2 Using amines or amino acids as mobile phase modifiers in chromatography |
| 05/19/2004 | CN1150318C Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies |
| 05/12/2004 | EP1418235A2 Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 05/06/2004 | EP1415006A2 Assay for identifying inhibitors of hiv rt dimerization |
| 05/06/2004 | EP1117645B1 Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use |
| 04/29/2004 | WO2003031623A8 Cocoa flavour precursor peptides |
| 04/29/2004 | US20040082758 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 04/21/2004 | EP1409710A1 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 04/15/2004 | WO2004011486A3 Method for solubilizing hydrophobic peptides and use thereof for inducing an antitumoral and/or anti-infectious ctl response |
| 04/07/2004 | EP1404377A2 Improved chelator conjugates |
| 04/06/2004 | US6716964 CtIP, a novel protein that interacts with CtBP and uses therefor |
| 03/25/2004 | WO2003020749A3 Ncam binding compounds |
| 03/25/2004 | US20040058865 Homing peptide multimers, their preparation and uses |
| 03/24/2004 | EP1399545A2 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 03/24/2004 | CN1484694A Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 03/24/2004 | CN1484497A Protein hydrol ysater enriched in peptides having a carboxy termina proline residue |
| 03/18/2004 | WO2004022084A1 A method of modulating cellular activity and molecules for use therein |
| 03/18/2004 | CA2497833A1 A method of modulating cellular activity and molecules for use therein |
| 02/26/2004 | WO2002083917A8 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 02/26/2004 | US20040038361 Novel protein kinase (NPK-110) |
| 02/25/2004 | EP1390499A2 Cell visual characteristic-modifying sequences |
| 02/11/2004 | EP1387854A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 02/05/2004 | WO2004011486A2 Method for solubilizing hydrophobic peptides and use thereof for inducing an antitumoral and/or anti-infectious ctl response |
| 02/05/2004 | WO2003037172A3 Endothelial-cell binding peptides for diagnosis and therapy |
| 02/05/2004 | US20040023290 Novel therapeutic agents that modulate enzymatic processes |
| 01/28/2004 | EP1383922A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |